GE HEALTHCARE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty approved drugs.
There are four US patents protecting GE HEALTHCARE drugs.
There are eighty patent family members on GE HEALTHCARE drugs in twenty-six countries and one hundred and thirty-seven supplementary protection certificates in eighteen countries.
Summary for GE HEALTHCARE
| International Patents: | 80 |
| US Patents: | 4 |
| Tradenames: | 58 |
| Ingredients: | 39 |
| NDAs: | 50 |
| Drug Master File Entries: | 5 |
Drugs and US Patents for GE HEALTHCARE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ge Healthcare | SODIUM IODIDE I 123 | sodium iodide i-123 | SOLUTION;ORAL | 017630-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ge Healthcare | MPI STANNOUS DIPHOSPHONATE | technetium tc-99m etidronate kit | INJECTABLE;INJECTION | 017667-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GE HEALTHCARE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | 4,021,481 | ⤷ Try a Trial |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | 4,396,597 | ⤷ Try a Trial |
| Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | 4,250,113 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GE HEALTHCARE Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 4875487 | ⤷ Try a Trial |
| Cyprus | 1113334 | ⤷ Try a Trial |
| Canada | 2694084 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for GE HEALTHCARE Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2182988 | 1590009-5 | Sweden | ⤷ Try a Trial | PRODUCT NAME: FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140826 |
| 1611115 | 2015C/005 | Belgium | ⤷ Try a Trial | PRODUCT NAME: FLUTEMETAMOL (18F); AUTHORISATION NUMBER AND DATE: EU/1/14/941 20140826 |
| 2932970 | 1890039-9 | Sweden | ⤷ Try a Trial | PRODUCT NAME: DOLUTEGRAVIR SODIUM + RILPIVIRINE HYDROCHLORIDE; REG. NO/DATE: EU/1/18/1282 20180518 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
